[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated

August 2017 | | ID: G429E93ABCFEN
Renub Research

US$ 2,200.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery, E-mail Delivery (Word)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Rising incidences of Pediatric cancer has provoked medical organizations towards development and implementation of sophisticated treatment procedures, which is “Proton Radiotherapy”. The efficiency of proton therapy continues to add trust of Pediatric cancer patients globally. The course of action is known for successfully destructing tumor cells by damaging their DNA during a targeted deposition of high-energy radiation dosage onto the tumor.

Globally the Pediatric cancer cases are increasing rapidly at a great pace. Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. United States dominates the proton therapy centers in the world because of its huge investment in the development of therapy centers as well as its elongated history of proton therapy.

USA leads the Pediatric Proton Therapy Market globally

USA has the highest pediatric proton therapy market share but gradually it will lose its market share in future, due to stiff competition from Germany, France, United Kingdom and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these 36 cancer types approximately, 15 percent of market share is taken by Ependymoma cancerous tumor.

United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market

The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.

United Kingdom, France and Germany is driving the Europe Pediatric Proton Therapy Market

Growing number of cancer diagnosed pediatric patients in Europe will enforce the many countries in Europe to expand proton therapy centers because of the demand. Improvement in Technology is playing a very crucial role in driving pediatric proton therapy market in Europe. Germany leads the pediatric proton therapy market in Europe. In 2010, France had the maximum market share of Pediatric Proton Therapy. Other countries studied in the reports are Switzerland, Czech Republic, Sweden, and United Kingdom.

Japan & China along with South Korea drives the Proton Therapy Market in Asia

Pediatric Proton therapy technology has immense potential as it is evident from the increasing number of proton therapy centers across Asia. Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.

Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated is the 20th report published by Renub Research on Proton Therapy Market. This 330 page report with 287 figures and 7 Tables provides 10 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Cancer Type Markets in USA, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies - IBA, Varian Medical Systems, Mitsubishi and Hitachi.

KEY QUESTIONS ANSWERED IN THE REPORT?
  • What is the Global Pediatric Proton Therapy Market and its growth potential in Future?
  • What is the Number of pediatric patients treated by Proton Beam Therapy worldwide?
  • What are the reimbursement policies for Proton Therapy across the world?
  • What is the Pediatric Proton Therapy Market in United States and Forecast?
  • What is the Number of Pediatric Proton Therapy Patients by age group in United States and Forecast
  • What is the Number of Pediatric Proton Therapy Patients by tumor type in United States and Forecast
  • What is the Pediatric Proton Therapy Market size in Asia (Japan, China and South Korea) and its growth potential in future?
  • What is the Number of Pediatric Proton Therapy patients treated in Asia (Japan, China and South Korea)?
  • What is the Pediatric Proton Therapy Market in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
  • What is the Number of Pediatric Proton Therapy Patients in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
  • What Type of Technology is being used at Proton Therapy Centers?
Key Companies Proton Therapy Sales Analysis (2010 – 2021)

1. IBA
2. Varian Medical Systems
3. Mitsubishi
4. Hitachi

Countries Pediatric Proton Therapy Market & Number of Patients studied in the Report

1. United States
2. United Kingdom
3. Switzerland
4. Germany
5. France
6. Sweden
7. Czech Republic
8. Japan
9. Korea
10. China
1 RESEARCH FINDINGS

2 GLOBAL PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)

2.1 Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
2.2 Pediatric Patients with Proton Therapy Potential Numbers & Forecast

3 GLOBAL PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)

3.1 Pediatric Proton Therapy Market & Forecast
3.2 Pediatric Proton Therapy - Potential Market & Forecast

4 GLOBAL PEDIATRIC PROTON THERAPY MARKET SHARE & FORECAST

4.1 By Region (Asia, Europe, USA) – Global Pediatric Proton Therapy Market Share
4.2 By Countries – Global Pediatric Proton Therapy Market Share

5 UNITED STATES PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)

5.1 United States Pediatric Proton Therapy Market & Forecast
5.2 United States Potential Pediatric Proton Therapy Market & Forecast

6 USA PEDIATRIC PROTON THERAPY MARKET BY AGE GROUP

6.1 By Age Group (<1) Year
6.2 By Age Group (1-4) Year
6.3 By Age Group (5-9) Year
6.4 By Age Group (10-14) Year
6.5 By Age Group (15-18) Year

7 USA PEDIATRIC PROTON THERAPY PATIENT NUMBER - ACTUAL AND POTENTIAL

7.1 USA Pediatric Patients Treated with Proton Therapy Numbers & Forecast
7.2 USA Pediatric Patients with Proton Therapy Potential Numbers & Forecast

8 USA PEDIATRIC PROTON THERAPY PATIENTS NUMBERS BY AGE GROUP

8.1 By Age (<1) Year
8.2 By Age (1- 4) Year
8.3 By Age (5- 9) Year
8.4 By Age (10-14) Year
8.5 By Age (15- 18) Year

9 TUMOR TYPES – USA PEDIATRICS PROTON THERAPY MARKET (2010 – 2021)

9.1 Glioma, Low Grade – Market & Forecast
9.2 Glioma, High Grade – Market & Forecast
9.3 Medulloblastoma – Market & Forecast
9.4 Ependymoma – Market & Forecast
9.5 ATRT – Market & Forecast
9.6 Germinoma, Pure – Market & Forecast
9.7 Germ Cell Tumor – Market & Forecast
9.8 Craniopharyngioma – Market & Forecast
9.9 PNET – Market & Forecast
9.1 Pineoblastoma – Market & Forecast
9.11 Chordoma/Chondrosarcoma – Market & Forecast
9.12 Meningioma – Market & Forecast
9.13 AVM – Market & Forecast
9.14 Adenoma – Market & Forecast
9.15 Choroid Plexus Carcinoma – Market & Forecast
9.16 Retinoblastoma – Market & Forecast
9.17 Osteosarcoma – Market & Forecast
9.18 Ewing Sarcoma – Market & Forecast
9.19 Rhabdomyosarcoma – Market & Forecast
9.2 Other Sarcoma, High Grade – Market & Forecast
9.21 Other Sarcoma, Low Grade – Market & Forecast
9.22 Teratoma – Market & Forecast
9.23 Neuroblastoma – Market & Forecast
9.24 Ganglioglioma – Market & Forecast
9.25 Wilm’s Tumor – Market & Forecast
9.26 Carcinoma (non-CPC) – Market & Forecast
9.27 Lymphoma, Hodgkin’s – Market & Forecast
9.28 Lymphoma, Non-hodgkin’s – Market & Forecast
9.29 Leukemia – Market & Forecast
9.3 Desmoid – Market & Forecast
9.31 Melanoma – Market & Forecast
9.32 Pineal Parenchymal Tumor – Market & Forecast
9.33 Esthesioneuroblastoma – Market & Forecast
9.34 Angiofibroma – Market & Forecast
9.35 Extrarenal Rhabdoid Tumor – Market & Forecast
9.36 Others – Market & Forecast

10 TUMOR TYPES USA PEDIATRICS PROTON THERAPY PATIENTS (2010 – 2021)

10.1 Glioma, Low Grade – Patient Numbers & Forecast
10.2 Glioma, High Grade - Patient Numbers & Forecast
10.3 Medulloblastoma - Patient Numbers & Forecast
10.4 Ependymoma - Patient Numbers & Forecast
10.5 ATRT - Patient Numbers & Forecast
10.6 Germinoma, pure - Patient Numbers & Forecast
10.7 Germ Cell Tumor - Patient Numbers & Forecast
10.8 Craniopharyngioma - Patient Numbers & Forecast
10.9 PNET - Patient Numbers & Forecast
10.1 Pineoblastoma - Patient Numbers & Forecast
10.11 Chordoma/Chondrosarcoma - Patient Numbers & Forecast
10.12 Meningioma - Patient Numbers & Forecast
10.13 AVM - Patient Numbers & Forecast
10.14 Adenoma - Patient Numbers & Forecast
10.15 Choroid Plexus Carcinoma - Patient Numbers & Forecast
10.16 Retinoblastoma - Patient Numbers & Forecast
10.17 Osteosarcoma - Patient Numbers & Forecast
10.18 Ewing Sarcoma - Patient Numbers & Forecast
10.19 Rhabdomyosarcoma - Patient Numbers & Forecast
10.2 Other Sarcoma, High Grade - Patient Numbers & Forecast
10.21 Other Sarcoma, Low Grade - Patient Numbers & Forecast
10.22 Teratoma - Patient Numbers & Forecast
10.23 Neuroblastoma - Patient Numbers & Forecast
10.24 Ganglioglioma - Patient Numbers & Forecast
10.25 Wilm’s Tumor - Patient Numbers & Forecast
10.26 Carcinoma (non-CPC) - Patient Numbers & Forecast
10.27 Lymphoma, Hodgkin’s - Patient Numbers & Forecast
10.28 Lymphoma, Non-hodgkin’s - Patient Numbers & Forecast
10.29 Leukemia - Patient Numbers & Forecast
10.3 Desmoid - Patient Numbers & Forecast
10.31 Melanoma - Patient Numbers & Forecast
10.32 Pineal Parenchymal Tumor - Patient Numbers & Forecast
10.33 Esthesioneuroblastoma - Patient Numbers & Forecast
10.34 Angiofibroma - Patient Numbers & Forecast
10.35 Extrarenal Rhabdoid Tumor - Patient Numbers & Forecast
10.36 Others - Patient Numbers & Forecast

11 EUROPE PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)

11.1 Europe Pediatric Proton Therapy Market
11.2 Europe Pediatric Proton Therapy Potential Market

12 EUROPE PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)

12.1 Europe – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
12.2 Europe – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

13 EUROPE PEDIATRIC PROTON THERAPY MARKET SHARE BY COUNTRIES

14 FRANCE PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET

14.1 France – Pediatric Proton Therapy Market & Forecast
14.2 France – Potential Pediatric Proton Therapy Market

15 FRANCE PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

15.1 France – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
15.2 France – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

16 GERMANY PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET

16.1 Germany – Pediatric Proton Therapy Market & Forecast
16.2 Germany – Potential Pediatric Proton Therapy Market

17 GERMANY PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

17.1 Germany – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
17.2 Germany – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

18 SWITZERLAND PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET

18.1 Switzerland Pediatric Proton Therapy Market & Forecast
18.2 Switzerland – Pediatric Proton Therapy Potential Market & Forecast

19 SWITZERLAND PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

19.1 Switzerland – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
19.2 Switzerland – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

20 SWEDEN PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET

20.1 Sweden - Pediatric Proton Therapy Market & Forecast
20.2 Sweden – Potential Pediatric Proton Therapy Market & Forecast

21 SWEDEN PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

21.1 Sweden – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
21.2 Sweden – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

22 CZECH REPUBLIC PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET

22.1 Czech Republic Pediatric Proton Therapy Market & Forecast
22.2 Czech Republic Potential Pediatric Proton Therapy Market & Forecast

23 CZECH REPUBLIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

23.1 Czech Republic – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
23.2 Czech Republic – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

24 UNITED KINGDOM PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET

24.1 United Kingdom Pediatric Proton Therapy Market & Forecast
24.2 United Kingdom Pediatric Proton therapy Market with NHS Expenditure
24.3 United Kingdom Pediatric Proton Therapy Potential Market & Forecast

25 UNITED KINGDOM PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

25.1 United Kingdom – Patients Treated with Proton Therapy Numbers & Forecast
25.2 Treatment Patterns of Pediatric Patients with Proton Therapy in United Kingdom and Abroad
25.3 United Kingdom – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

26 ASIA PEDIATRIC PROTON THERAPY MARKET (ACTUAL & POTENTIAL)

26.1 Asia Pediatric Proton Therapy Market & Forecast
26.2 Asia Pediatric Proton Therapy - Potential Market & Forecast

27 ASIA PEDIATRIC PROTON THERAPY NUMBER OF PATIENTS (ACTUAL & POTENTIAL)

27.1 Asia – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
27.2 Asia – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

28 BY COUNTRIES – ASIA PEDIATRIC PROTON THERAPY MARKET SHARE

29 JAPAN PEDIATRIC PROTON THERAPY - ACTUAL & POTENTIAL MARKET

29.1 Japan – Pediatric Proton Therapy Market & Forecast
29.2 Japan – Potential Pediatric Proton Therapy Market & Forecast

30 JAPAN PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

30.1 Japan – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
30.2 Japan – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

31 CHINA PEDIATRIC PROTON THERAPY MARKET - ACTUAL & POTENTIAL MARKET

31.1 China – Pediatric Proton Therapy Market & Forecast
31.2 China – Potential Pediatric Proton Therapy Market

32 CHINA PEDIATRIC PROTON THERAPY PATIENTS NUMBER – ACTUAL AND POTENTIAL

32.1 China – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
32.2 China – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

33 SOUTH KOREA PEDIATRIC PROTON THERAPY MARKET – ACTUAL & POTENTIAL MARKET

33.1 South Korea – Pediatric Proton Therapy Market & Forecast
33.2 South Korea – Potential Pediatric Proton Therapy Market & Forecast

34 SOUTH KOREA PEDIATRIC PROTON THERAPY PATIENT NUMBER – ACTUAL AND POTENTIAL

34.1 South Korea – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
34.2 South Korea – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

35 COMPONENTS OF A STANDARD PROTON THERAPY CENTER

35.1 Proton Accelerator
  35.1.1 Synchrotrons (example: LLUMC at Loma Linda)
  35.1.2 Cyclotrons (example: MGH Boston)
  35.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
  35.1.4 H-minus Synchrotrons
  35.1.5 Separated Sector Cyclotrons
  35.1.6 Super-conducting Cyclotrons
  35.1.7 Fast Cycling Synchrotron
35.2 Beam Transport System
35.3 Beam Delivery System
  35.3.1 The Passive Scattering Technique
  35.3.2 Beam Scanning
35.4 Nozzle
  35.4.1 Single Scattering
  35.4.2 Double Scattering
  35.4.3 Uniform Scanning Nozzle
  35.4.4 Pencil Scanning Nozzle
35.5 Treatment Planning System
35.6 Image Viewers
35.7 Patient Positioning System (PPS)
35.8 Human Resource

36 PROTON THERAPY – DRIVING FACTORS

36.1 Technology Advancement
36.2 Rising Prevalence of Pediatric Cancer Globally

37 PROTON THERAPY – CHALLENGES

37.1 Requires Huge Investment
37.2 Operations Challenges

38 GLOBAL PROTON THERAPY - COMPANY ANALYSIS (2010-2021)

38.1 IBA Proton Therapy
  38.1.1 Sales Analysis
  38.1.2 IBA List of Proton Therapy Centers
38.2 Varian Medical Systems
  38.2.1 Sales Analysis
38.3 Mitsubishi Electric Corporation
  38.3.1 Sales Analysis
  38.3.2 Mitsubishi List of Proton Therapy Center
38.4 Hitachi
  38.4.1 Sales Analysis
  38.4.2 Hitachi List of Proton Therapy Center

39 PROTON THERAPY – REIMBURSEMENT POLICIES

39.1 Proton Therapy Reimbursement Policies for Patients
39.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers


More Publications